About (2S)-2-[[(2R)-3-amino-2-(2,5-dioxopyrrol-1-yl)propanoyl]amino]-N-[(2S)-1-[4-[[(1R,6R,8R,9R,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-12-hydroxy-3-oxo-17-(6-oxo-1H-purin-9-yl)-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-1-oxopropan-2-yl]-3-methylbutanamide
(2S)-2-[[(2R)-3-amino-2-(2,5-dioxopyrrol-1-yl)propanoyl]amino]-N-[(2S)-1-[4-[[(1R,6R,8R,9R,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-12-hydroxy-3-oxo-17-(6-oxo-1H-purin-9-yl)-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-1-oxopropan-2-yl]-3-methylbutanamide (PubChem CID 153234482) has the molecular formula C42H48F2N14O14P2S2
and a molecular weight of 1137.01 g/mol. Its IUPAC name is (2S)-2-[[(2R)-3-amino-2-(2,5-dioxopyrrol-1-yl)propanoyl]amino]-N-[(2S)-1-[4-[[(1R,6R,8R,9R,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-12-hydroxy-3-oxo-17-(6-oxo-1H-purin-9-yl)-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-1-oxopropan-2-yl]-3-methylbutanamide.
Frequently Asked Questions
What is the IUPAC name of (2S)-2-[[(2R)-3-amino-2-(2,5-dioxopyrrol-1-yl)propanoyl]amino]-N-[(2S)-1-[4-[[(1R,6R,8R,9R,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-12-hydroxy-3-oxo-17-(6-oxo-1H-purin-9-yl)-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-1-oxopropan-2-yl]-3-methylbutanamide?
The IUPAC name of (2S)-2-[[(2R)-3-amino-2-(2,5-dioxopyrrol-1-yl)propanoyl]amino]-N-[(2S)-1-[4-[[(1R,6R,8R,9R,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-12-hydroxy-3-oxo-17-(6-oxo-1H-purin-9-yl)-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-1-oxopropan-2-yl]-3-methylbutanamide (CID 153234482) is (2S)-2-[[(2R)-3-amino-2-(2,5-dioxopyrrol-1-yl)propanoyl]amino]-N-[(2S)-1-[4-[[(1R,6R,8R,9R,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-12-hydroxy-3-oxo-17-(6-oxo-1H-purin-9-yl)-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-1-oxopropan-2-yl]-3-methylbutanamide.
What is the SMILES notation for (2S)-2-[[(2R)-3-amino-2-(2,5-dioxopyrrol-1-yl)propanoyl]amino]-N-[(2S)-1-[4-[[(1R,6R,8R,9R,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-12-hydroxy-3-oxo-17-(6-oxo-1H-purin-9-yl)-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-1-oxopropan-2-yl]-3-methylbutanamide?
The canonical SMILES for (2S)-2-[[(2R)-3-amino-2-(2,5-dioxopyrrol-1-yl)propanoyl]amino]-N-[(2S)-1-[4-[[(1R,6R,8R,9R,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-12-hydroxy-3-oxo-17-(6-oxo-1H-purin-9-yl)-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-1-oxopropan-2-yl]-3-methylbutanamide is CC(C)[C@H](NC(=O)[C@@H](CN)N1C(=O)C=CC1=O)C(=O)N[C@@H](C)C(=O)Nc1ccc(CSP2(=O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](F)[C@@H]3OP(O)(=S)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]cnc54)[C@H](F)[C@@H]3O2)cc1.
What is the InChIKey of (2S)-2-[[(2R)-3-amino-2-(2,5-dioxopyrrol-1-yl)propanoyl]amino]-N-[(2S)-1-[4-[[(1R,6R,8R,9R,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-12-hydroxy-3-oxo-17-(6-oxo-1H-purin-9-yl)-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-1-oxopropan-2-yl]-3-methylbutanamide?
The InChIKey is WQFLZCNGCGKAIF-YLMZJGJXSA-N. The full InChI is InChI=1S/C42H48F2N14O14P2S2/c1-18(2)29(55-38(62)22(10-45)58-25(59)8-9-26(58)60)40(64)53-19(3)37(61)54-21-6-4-20(5-7-21)13-76-74(66)68-12-24-32(27(43)41(70-24)56-16-51-30-34(46)47-14-48-35(30)56)71-73(65,75)67-11-23-33(72-74)28(44)42(69-23)57-17-52-31-36(57)49-15-50-39(31)63/h4-9,14-19,22-24,27-29,32-33,41-42H,10-13,45H2,1-3H3,(H,53,64)(H,54,61)(H,55,62)(H,65,75)(H2,46,47,48)(H,49,50,63)/t19-,22+,23+,24+,27+,28+,29-,32+,33+,41+,42+,73?,74?/m0/s1.
What are the key properties of (2S)-2-[[(2R)-3-amino-2-(2,5-dioxopyrrol-1-yl)propanoyl]amino]-N-[(2S)-1-[4-[[(1R,6R,8R,9R,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-12-hydroxy-3-oxo-17-(6-oxo-1H-purin-9-yl)-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-1-oxopropan-2-yl]-3-methylbutanamide?
(2S)-2-[[(2R)-3-amino-2-(2,5-dioxopyrrol-1-yl)propanoyl]amino]-N-[(2S)-1-[4-[[(1R,6R,8R,9R,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-12-hydroxy-3-oxo-17-(6-oxo-1H-purin-9-yl)-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-1-oxopropan-2-yl]-3-methylbutanamide has a molecular weight of 1137.01 g/mol, XLogP of 0.92, 14 rotatable bonds, 7 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-2-[[(2R)-3-amino-2-(2,5-dioxopyrrol-1-yl)propanoyl]amino]-N-[(2S)-1-[4-[[(1R,6R,8R,9R,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-12-hydroxy-3-oxo-17-(6-oxo-1H-purin-9-yl)-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-1-oxopropan-2-yl]-3-methylbutanamide is sourced from PubChem (CID 153234482), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).